Fujifilm signs manufacturing contract with VLP Therapeutics for COVID-19 vaccine candidate

On Thursday, in a statement Japan’s Fujifilm Holdings Corp said, it has signed a manufacturing contract with U.S.-based VLP Therapeutics for manufacturing a COVID-19 vaccine.

In a statement both companies said, “Fujifilm will use its manufacturing facilities and infrastructure to handle development of the vaccine for clinical trials”.

VLP’s RNA-based vaccine candidate was selected for funding by the Japan Agency for Medical Research and Development.

Ert h least decade, Fujifilm has increasingly drifted towards healthcare from its traditional photography and office solutions businesses.

Last month, it concluded a successful Phase-3 clinical trial of its Avigan drug for use in COVID-19 patients.



Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: